Yaroshetskiy, Andrey I. http://orcid.org/0000-0002-1484-092X
Avdeev, Sergey N. http://orcid.org/0000-0002-5999-2150
Politov, Mikhail E. http://orcid.org/0000-0003-0623-4927
Nogtev, Pavel V. http://orcid.org/0000-0002-5553-0880
Beresneva, Victoria G. http://orcid.org/0000-0002-6587-1953
Sorokin, Yury D. http://orcid.org/0000-0001-9720-8833
Konanykhin, Vasily D. http://orcid.org/0000-0002-6558-1227
Krasnoshchekova, Anna P. http://orcid.org/0000-0001-6986-1368
Merzhoeva, Zamira M. http://orcid.org/0000-0002-3174-5000
Tsareva, Natalia A. http://orcid.org/0000-0001-9357-4924
Trushenko, Natalia V. http://orcid.org/0000-0002-0685-4133
Mandel, Irina A. http://orcid.org/0000-0001-9437-6591
Yavorovskiy, Andrey G. http://orcid.org/0000-0001-5103-0304
Article History
Received: 10 June 2021
Accepted: 28 February 2022
First Online: 4 March 2022
Declarations
:
: The study was approved by the Institutional Ethics Committee of Sechenov University (approval number: 16–20). Written informed consent was waived owing to the observational nature of the study. The waiver was approved by the Institutional Ethics Committee of Sechenov University (approval number: 16–20).
: Not applicable.
: AIY reported personal fees from GE, Philips Respironics, Covidien, Fisher & Paykel, Drager, Triton Electronics, Mindray, Pfizer, BBraun, Gilead outside the submitted work. SNA reported personal fees from Behringer Ingelheim, Pfizer, Novartis, AstraZeneca, Chiesi outside the submitted work. No other disclosers were reported.